Physician profile
Angela E Gardner
NPI 1922050483
$2,833.87
in general payments reported to CMS, 2019-2025
16 companies · $745 in 2025
The $745 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $61.99 · 2021: $134 · 2022: $370 · 2023: $602 · 2024: $487 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,834.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $569.36 | 2023-2025 | Precision7, Tryptyr, Rocklatan |
| Bausch & Lomb Americas INC. | $543.71 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $394.80 | 2019-2021 | |
| Sight Sciences, INC. | $276.90 | 2022-2023 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $186.73 | 2024-2025 | Xdemvy |
| Coopervision INC. | $170.41 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Abbvie INC. | $151.24 | 2023 | |
| Astellas Pharma US INC | $140.38 | 2024 | Izervay |
| Spark Therapeutics, INC. | $91.82 | 2019 | |
| Amgen INC. | $81.69 | 2024 | Tepezza |
| Lkc Technologies, INC. | $66.77 | 2022 | |
| Maculogix, INC. | $50.00 | 2020 | |
| Oyster Point Pharma, INC. | $48.50 | 2022-2024 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $34.00 | 2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $18.47 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $9.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.